Literature DB >> 17408248

Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.

Rajsekhar Guddneppanavar1, Jayati Roy Choudhury, Alexander R Kheradi, Bartlett D Steen, Gilda Saluta, Gregory L Kucera, Cynthia S Day, Ulrich Bierbach.   

Abstract

The following complexes of type [PtCl(R)(ACRAMTU)](NO3)2 (ACRAMTU = 1-[2-(acridin-9-ylamino)ethyl]-1,3-dimethylthiourea)), derived from prototype 1 (with R = ethane-1,2-diamine), were synthesized: 2 (with R = (1R,2R)-1,2-diaminocyclohexane), 3 (with R = propane-1,3-diamine), 4 (with R = N1,N1,N2,N2-tetramethylethane-1,2-diamine), and 5 (with R = 2,2'-bipyridine). The DNA sequence specificity of the conjugates and their antiproliferative potential in HL-60 and H460 cells were investigated. Conjugate 3 showed the strongest non-cisplatin-type DNA damage in polymerase stop assays and superior cell kill efficacy in H460 lung cancer (IC50 = 70 nM).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408248     DOI: 10.1021/jm0614376

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

Review 1.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

2.  Comparative chemogenomics to examine the mechanism of action of dna-targeted platinum-acridine anticancer agents.

Authors:  Kahlin Cheung-Ong; Kyung Tae Song; Zhidong Ma; Daniel Shabtai; Anna Y Lee; David Gallo; Lawrence E Heisler; Grant W Brown; Ulrich Bierbach; Guri Giaever; Corey Nislow
Journal:  ACS Chem Biol       Date:  2012-09-05       Impact factor: 5.100

3.  Probing platinum-adenine-n3 adduct formation with DNA minor-groove binding agents.

Authors:  Lu Rao; Tiffany K West; Gilda Saluta; Gregory L Kucera; Ulrich Bierbach
Journal:  Chem Res Toxicol       Date:  2010-07-19       Impact factor: 3.739

4.  Unusual Reactivity of a Potent Platinum-Acridine Hybrid Antitumor Agent.

Authors:  Leigh A Graham; Gary M Wilson; Tiffany K West; Cynthia S Day; Gregory L Kucera; Ulrich Bierbach
Journal:  ACS Med Chem Lett       Date:  2011-09-08       Impact factor: 4.345

Review 5.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

6.  Rates of intercalator-driven platination of DNA determined by a restriction enzyme cleavage inhibition assay.

Authors:  Jayati Roy Choudhury; Lu Rao; Ulrich Bierbach
Journal:  J Biol Inorg Chem       Date:  2010-11-18       Impact factor: 3.358

7.  Replacement of a thiourea-S with an amidine-NH donor group in a platinum-acridine antitumor compound reduces the metal's reactivity with cysteine sulfur.

Authors:  Zhidong Ma; Lu Rao; Ulrich Bierbach
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

8.  Synthesis and biological evaluation of platinum-acridine hybrid agents modified with bipyridine non-leaving groups.

Authors:  Alexander R Kheradi; Gilda Saluta; Gregory L Kucera; Cynthia S Day; Ulrich Bierbach
Journal:  Bioorg Med Chem Lett       Date:  2009-05-18       Impact factor: 2.823

9.  Effect of linkage geometry on biological activity in thiourea- and guanidine-substituted acridines and platinum-acridines.

Authors:  Zhidong Ma; Gilda Saluta; Gregory L Kucera; Ulrich Bierbach
Journal:  Bioorg Med Chem Lett       Date:  2008-05-16       Impact factor: 2.823

10.  A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer.

Authors:  Zhidong Ma; Jayati Roy Choudhury; Marcus W Wright; Cynthia S Day; Gilda Saluta; Gregory L Kucera; Ulrich Bierbach
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.